Skip to content

Autologous Epidermal Cell Treat for Nonhealing Postoperative Wound

Department of Burn Surgery, The First Affiliated Hospital of Sun Yat-sen University

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06173908
Enrollment
120
Registered
2023-12-18
Start date
2018-01-01
Completion date
2024-12-31
Last updated
2023-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healing Wound

Brief summary

Postoperative incision healing (Postoperative incision non - ranging) occurred in the surgical incision more than 2 weeks after the operation is still not healing wounds. At present, direct suture, autologous skin graft transplantation, conventional dressing change and negative pressure wound therapy are still the first-line treatment options for postoperative wound nonunion. However, the wound healing time is long and the wound healing rate is low. Autologous epidermal basal cell suspension is derived from the basal layer of the epidermis and contains 1-10% epidermal stem cells. Therefore, we plan to carry out a multi-center, prospective randomized controlled clinical trial, aiming to verify whether this technique can promote wound healing.

Detailed description

Postoperative incision healing (Postoperative incision non - ranging) occurred in the surgical incision more than 2 weeks after the operation is still not healing wounds, show the incision infection, effusion, hemorrhage, empyema, skin lesions and skin defect. It has a high morbidity and the treatment cycle is long, the social and economic burden is heavy. At present, direct suture, autologous skin graft transplantation, conventional dressing change and negative pressure wound therapy are still the first-line treatment options for postoperative wound nonunion. However, the wound healing time is long and the wound healing rate is low. Therefore, how to improve the wound healing rate is an urgent problem to be solved. The present study indicated that the disturbance of wound microenvironment was the main reason for the wound healing. Autologous epidermal basal cell suspension is derived from the basal layer of the epidermis and contains 1-10% epidermal stem cells. Therefore, we plan to carry out a multi-center, prospective randomized controlled clinical trial, aiming to verify whether this technique can promote wound healing.

Interventions

PROCEDUREcell treatment

Autologous epidermal basal cells were used to repair nonhealing postoperative wound

anyother treatments except autologous epidermal basal cells were used to repair nonhealing postoperative wound

Sponsors

First Affiliated Hospital, Sun Yat-Sen University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
No minimum to 85 Years
Healthy volunteers
No

Inclusion criteria

* (1) the age of the subject on the day of signing the informed consent is 18 years old or above; (2) the diagnosis was non-union of incision, and the diagnosis criteria of non-union of incision were as follows: non-union of incision \> for 2 weeks after various surgeries; (3) patients with stable vital signs, who are proved to be tolerable to surgery by routine examination; (4) the patient is in good mental state, can follow the doctor's advice and return to the hospital regularly; (5) understand and willing to participate in this clinical trial and provide the signed informed consent

Exclusion criteria

* (1) local wound complicated with malignant tumor; (2) during the screening period, patients showed immunosuppression due to potential diseases, long-term immunosuppressive therapy or the use of large doses of glucocorticoid (i.e. (3) patients with mental diseases; (4) patients with serious uncontrolled diseases or acute systemic infections and other serious visceral diseases such as heart, lung and brain diseases; (5) if the researcher considers the inclusion inappropriate; (6) the patients were pregnant women, fertile women who did not take appropriate contraceptive measures, lactating women during the screening period or women who planned to become pregnant within 1 month after the end of the study; (7) the patient participated in this study at any time in the past and the patient is participating in other clinical trials.

Design outcomes

Primary

MeasureTime frameDescription
healing ratepostoperative day 7, 14, 21, 28wound healing rate

Secondary

MeasureTime frameDescription
healing timewhen the wound was complete healed,through study completion, an average of 1 or 2 weekswound healing time
recurrence ratepostoperative month 3recurrence rate
Wound reduction ratepostoperative day 7, 14, 21, 28Wound reduction rate

Countries

China

Contacts

Primary ContactJiayuan Zhu
zhujiay@mail.sysu.edu.cn13802751558

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026